Detalhe da pesquisa
1.
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature
; 603(7903): 934-941, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130560
2.
Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome.
Am J Med Genet A
; : e63788, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864234
3.
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Front Oncol
; 11: 744739, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540703
4.
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.
Nat Commun
; 12(1): 6938, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34836966
5.
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Clin Cancer Res
; 26(19): 5232-5245, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546647
6.
Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients.
Front Immunol
; 10: 121, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761153
7.
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Nat Med
; 25(3): 477-486, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742122
8.
Precision Medicine in Pediatric Neurooncology: A Review.
ACS Chem Neurosci
; 9(1): 11-28, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29199818